Joseph Pantginis
Stock Analyst at HC Wainwright & Co.
(3.25)
# 1,057
Out of 5,182 analysts
901
Total ratings
41.44%
Success rate
3.85%
Average return
Main Sectors:
Stocks Rated by Joseph Pantginis
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| CMPX Compass Therapeutics | Reiterates: Buy | $24 | $1.89 | +1,169.84% | 19 | Apr 27, 2026 | |
| GUTS Fractyl Health | Reiterates: Buy | $8 | $0.65 | +1,130.96% | 4 | Apr 24, 2026 | |
| STTK Shattuck Labs | Maintains: Buy | $6 → $18 | $7.61 | +136.53% | 20 | Apr 20, 2026 | |
| ANL Adlai Nortye | Maintains: Buy | $16 → $20 | $11.81 | +69.35% | 6 | Apr 20, 2026 | |
| PDSB PDS Biotechnology | Reiterates: Buy | $15 | $1.04 | +1,342.31% | 34 | Apr 15, 2026 | |
| LGND Ligand Pharmaceuticals | Maintains: Buy | $239 → $243 | $230.96 | +5.21% | 24 | Apr 14, 2026 | |
| TVTX Travere Therapeutics | Reiterates: Buy | $47 | $41.10 | +14.36% | 7 | Apr 14, 2026 | |
| CVKD Cadrenal Therapeutics | Maintains: Buy | $32 → $13 | $5.42 | +140.07% | 7 | Apr 7, 2026 | |
| APRE Aprea Therapeutics | Maintains: Buy | $4 → $1.2 | $0.82 | +45.81% | 17 | Mar 31, 2026 | |
| PHAR Pharming Group | Reiterates: Buy | $37 | $16.51 | +124.12% | 18 | Mar 24, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $9 | $1.57 | +475.08% | 14 | Mar 24, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $6 | $1.68 | +258.21% | 25 | Mar 23, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $102 | $33.10 | +208.16% | 36 | Mar 23, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $97 | $41.84 | +131.84% | 26 | Mar 20, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $60 | $34.68 | +73.04% | 29 | Mar 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $0.90 | - | 19 | Mar 9, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $13 | $5.68 | +128.87% | 1 | Feb 25, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $17 | $2.23 | +664.04% | 5 | Feb 23, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $9 → $15 | $9.66 | +55.28% | 16 | Feb 23, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $0.57 | - | 13 | Jan 29, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $11 | $1.72 | +539.53% | 20 | Jan 22, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $40 | $8.93 | +347.93% | 29 | Jan 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $240 → $310 | $271.33 | +14.25% | 35 | Jan 9, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $120 → $136 | $62.39 | +117.98% | 51 | Dec 22, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $12 | $1.85 | +550.41% | 1 | Dec 16, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $5 → $3 | $0.70 | +328.88% | 20 | Dec 12, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $21 → $7 | $5.12 | +36.69% | 3 | Dec 5, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $20 → $9 | $3.38 | +166.67% | 30 | Oct 29, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Assumes: Buy | $52 | $28.81 | +80.49% | 1 | Oct 20, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $57 | $30.90 | +84.50% | 27 | Oct 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $25 | $1.16 | +2,055.17% | 17 | Sep 22, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $16 | $1.93 | +731.17% | 30 | Sep 19, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $0.79 | - | 26 | Sep 15, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $15 | $3.21 | +367.29% | 17 | Aug 21, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $50 → $42 | $33.90 | +23.91% | 36 | Aug 20, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $5 → $30 | $28.75 | +4.35% | 1 | Aug 5, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $15 → $10 | $8.68 | +15.27% | 10 | Aug 4, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $0.64 | - | 23 | Jul 30, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $42 | $30.75 | +36.59% | 1 | Jun 30, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $14 | $1.20 | +1,066.57% | 2 | Jun 25, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $4 | $1.20 | +234.45% | 31 | Jun 24, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $100 | $2.53 | +3,852.57% | 2 | Jun 18, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Assumes: Buy | $6 | $2.34 | +156.96% | 1 | Jun 17, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $26 | $2.65 | +881.13% | 14 | Jun 17, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $280 | $2.32 | +11,968.97% | 3 | Jun 11, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Assumes: Buy | $17 | $0.58 | +2,831.03% | 1 | May 19, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $40 → $18 | $1.62 | +1,011.11% | 30 | May 6, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Neutral | n/a | $3.08 | - | 9 | Apr 9, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $31 | $5.98 | +418.39% | 31 | Apr 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $12 | $0.59 | +1,933.90% | 1 | Apr 3, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $11 | $1.40 | +685.71% | 7 | Mar 19, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $17 → $7 | $21.22 | -67.01% | 29 | Feb 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $25 | $0.72 | +3,386.26% | 4 | Oct 2, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $100 | $0.77 | +12,953.13% | 7 | May 16, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $1.54 | - | 6 | Dec 1, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $0.42 | - | 2 | Jan 31, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Assumes: Buy | $18 → $33 | $35.10 | -5.98% | 2 | Nov 14, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $60 → $78 | $5.42 | +1,340.44% | 1 | Mar 24, 2017 |
Compass Therapeutics
Apr 27, 2026
Reiterates: Buy
Price Target: $24
Current: $1.89
Upside: +1,169.84%
Fractyl Health
Apr 24, 2026
Reiterates: Buy
Price Target: $8
Current: $0.65
Upside: +1,130.96%
Shattuck Labs
Apr 20, 2026
Maintains: Buy
Price Target: $6 → $18
Current: $7.61
Upside: +136.53%
Adlai Nortye
Apr 20, 2026
Maintains: Buy
Price Target: $16 → $20
Current: $11.81
Upside: +69.35%
PDS Biotechnology
Apr 15, 2026
Reiterates: Buy
Price Target: $15
Current: $1.04
Upside: +1,342.31%
Ligand Pharmaceuticals
Apr 14, 2026
Maintains: Buy
Price Target: $239 → $243
Current: $230.96
Upside: +5.21%
Travere Therapeutics
Apr 14, 2026
Reiterates: Buy
Price Target: $47
Current: $41.10
Upside: +14.36%
Cadrenal Therapeutics
Apr 7, 2026
Maintains: Buy
Price Target: $32 → $13
Current: $5.42
Upside: +140.07%
Aprea Therapeutics
Mar 31, 2026
Maintains: Buy
Price Target: $4 → $1.2
Current: $0.82
Upside: +45.81%
Pharming Group
Mar 24, 2026
Reiterates: Buy
Price Target: $37
Current: $16.51
Upside: +124.12%
Mar 24, 2026
Reiterates: Buy
Price Target: $9
Current: $1.57
Upside: +475.08%
Mar 23, 2026
Reiterates: Buy
Price Target: $6
Current: $1.68
Upside: +258.21%
Mar 23, 2026
Reiterates: Buy
Price Target: $102
Current: $33.10
Upside: +208.16%
Mar 20, 2026
Reiterates: Buy
Price Target: $97
Current: $41.84
Upside: +131.84%
Mar 13, 2026
Reiterates: Buy
Price Target: $60
Current: $34.68
Upside: +73.04%
Mar 9, 2026
Downgrades: Neutral
Price Target: n/a
Current: $0.90
Upside: -
Feb 25, 2026
Initiates: Buy
Price Target: $13
Current: $5.68
Upside: +128.87%
Feb 23, 2026
Reiterates: Buy
Price Target: $17
Current: $2.23
Upside: +664.04%
Feb 23, 2026
Maintains: Buy
Price Target: $9 → $15
Current: $9.66
Upside: +55.28%
Jan 29, 2026
Downgrades: Neutral
Price Target: n/a
Current: $0.57
Upside: -
Jan 22, 2026
Upgrades: Buy
Price Target: $11
Current: $1.72
Upside: +539.53%
Jan 13, 2026
Reiterates: Buy
Price Target: $40
Current: $8.93
Upside: +347.93%
Jan 9, 2026
Reiterates: Buy
Price Target: $240 → $310
Current: $271.33
Upside: +14.25%
Dec 22, 2025
Maintains: Buy
Price Target: $120 → $136
Current: $62.39
Upside: +117.98%
Dec 16, 2025
Initiates: Buy
Price Target: $12
Current: $1.85
Upside: +550.41%
Dec 12, 2025
Maintains: Buy
Price Target: $5 → $3
Current: $0.70
Upside: +328.88%
Dec 5, 2025
Maintains: Buy
Price Target: $21 → $7
Current: $5.12
Upside: +36.69%
Oct 29, 2025
Maintains: Buy
Price Target: $20 → $9
Current: $3.38
Upside: +166.67%
Oct 20, 2025
Assumes: Buy
Price Target: $52
Current: $28.81
Upside: +80.49%
Oct 8, 2025
Reiterates: Buy
Price Target: $57
Current: $30.90
Upside: +84.50%
Sep 22, 2025
Reiterates: Buy
Price Target: $25
Current: $1.16
Upside: +2,055.17%
Sep 19, 2025
Reiterates: Buy
Price Target: $16
Current: $1.93
Upside: +731.17%
Sep 15, 2025
Downgrades: Neutral
Price Target: n/a
Current: $0.79
Upside: -
Aug 21, 2025
Reiterates: Buy
Price Target: $15
Current: $3.21
Upside: +367.29%
Aug 20, 2025
Maintains: Buy
Price Target: $50 → $42
Current: $33.90
Upside: +23.91%
Aug 5, 2025
Maintains: Buy
Price Target: $5 → $30
Current: $28.75
Upside: +4.35%
Aug 4, 2025
Maintains: Buy
Price Target: $15 → $10
Current: $8.68
Upside: +15.27%
Jul 30, 2025
Downgrades: Neutral
Price Target: n/a
Current: $0.64
Upside: -
Jun 30, 2025
Initiates: Buy
Price Target: $42
Current: $30.75
Upside: +36.59%
Jun 25, 2025
Reiterates: Buy
Price Target: $14
Current: $1.20
Upside: +1,066.57%
Jun 24, 2025
Reiterates: Buy
Price Target: $4
Current: $1.20
Upside: +234.45%
Jun 18, 2025
Reiterates: Buy
Price Target: $100
Current: $2.53
Upside: +3,852.57%
Jun 17, 2025
Assumes: Buy
Price Target: $6
Current: $2.34
Upside: +156.96%
Jun 17, 2025
Reiterates: Buy
Price Target: $26
Current: $2.65
Upside: +881.13%
Jun 11, 2025
Reiterates: Buy
Price Target: $280
Current: $2.32
Upside: +11,968.97%
May 19, 2025
Assumes: Buy
Price Target: $17
Current: $0.58
Upside: +2,831.03%
May 6, 2025
Maintains: Buy
Price Target: $40 → $18
Current: $1.62
Upside: +1,011.11%
Apr 9, 2025
Reiterates: Neutral
Price Target: n/a
Current: $3.08
Upside: -
Apr 8, 2025
Reiterates: Buy
Price Target: $31
Current: $5.98
Upside: +418.39%
Apr 3, 2025
Initiates: Buy
Price Target: $12
Current: $0.59
Upside: +1,933.90%
Mar 19, 2025
Reiterates: Buy
Price Target: $11
Current: $1.40
Upside: +685.71%
Feb 13, 2025
Maintains: Buy
Price Target: $17 → $7
Current: $21.22
Upside: -67.01%
Oct 2, 2024
Reiterates: Buy
Price Target: $25
Current: $0.72
Upside: +3,386.26%
May 16, 2024
Reiterates: Buy
Price Target: $100
Current: $0.77
Upside: +12,953.13%
Dec 1, 2021
Downgrades: Neutral
Price Target: n/a
Current: $1.54
Upside: -
Jan 31, 2018
Downgrades: Neutral
Price Target: n/a
Current: $0.42
Upside: -
Nov 14, 2017
Assumes: Buy
Price Target: $18 → $33
Current: $35.10
Upside: -5.98%
Mar 24, 2017
Reiterates: Buy
Price Target: $60 → $78
Current: $5.42
Upside: +1,340.44%